Clinical Trial Update: Efficacy Optimizing Research of Lamivudine Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy of lamivudine therapy for compensated chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (Epivir) (lamivudine)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Compensated Chronic Hepatitis B | Phase 4 | Status: COMPLETED